Literature DB >> 27124386

Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Michael F Salvatore1, Erin S Calipari2, Sara R Jones2.   

Abstract

Tyrosine hydroxylase (TH) and dopamine transporters (DATs) regulate dopamine (DA) neurotransmission at the biosynthesis and reuptake steps, respectively. Dysfunction or loss of these proteins occurs in impaired locomotor or addictive behavior, but little is known about the influence of DAT expression on TH function. Differences in TH phosphorylation, DA tissue content, l-DOPA biosynthesis, and DA turnover exist between the somatodendritic and terminal field compartments of nigrostriatal and mesoaccumbens pathways. We examined whether differential DAT expression affects these compartmental differences in DA regulation by comparing TH expression and phosphorylation at ser31 and ser40. In heterozygous DAT knockout (KO) (+/-) mice, DA tissue content and DA turnover were unchanged relative to wild-type mice, despite a 40% reduction in DAT protein expression. In DAT KO (-/-) mice, DA turnover increased in all DA compartments, but DA tissue content decreased (90-96%) only in terminal fields. TH protein expression and phosphorylation were differentially affected within DA pathway compartments by relative expression of DAT. TH protein decreased (∼74%), though to a significantly lesser extent than DA, in striatum and nucleus accumbens (NAc) in DAT -/- mice, with no decrease in substantia nigra or ventral tegmental area. Striatal ser31 TH phosphorylation and recovery of DA relative to TH protein expression in DAT +/- and DAT -/- mice decreased, whereas ser40 TH phosphorylation increased ∼2- to 3-fold in striatum and NAc of DAT -/- mice. These results suggest that DAT expression affects TH expression and phosphorylation largely in DA terminal field compartments, further corroborating evidence for dichotomous regulation of TH between somatodendritic and terminal field compartments of the nigrostriatal and mesoaccumbens pathways.

Entities:  

Keywords:  Tyrosine hydroxylase; dopamine neurotransmission; dopamine transporters; l-DOPA

Mesh:

Substances:

Year:  2016        PMID: 27124386      PMCID: PMC4956566          DOI: 10.1021/acschemneuro.6b00064

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  57 in total

1.  Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme.

Authors:  J Wu; J W Haycock; M Goldstein
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

2.  Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.

Authors:  M F Salvatore; J C Waymire; J W Haycock
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

3.  Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates.

Authors:  Matthew J Hansard; Lance A Smith; Michael J Jackson; Sharon C Cheetham; Peter Jenner
Journal:  Eur J Pharmacol       Date:  2002-09-13       Impact factor: 4.432

4.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

5.  The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration.

Authors:  H Sun; E S Calipari; T J R Beveridge; S R Jones; R Chen
Journal:  Neuroscience       Date:  2015-08-28       Impact factor: 3.590

6.  Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.

Authors:  Evgeny A Budygin; Mark S Brodie; Tatyana D Sotnikova; Yolanda Mateo; Carrie E John; Michel Cyr; Raul R Gainetdinov; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

7.  Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.

Authors:  Ichiro Kawahata; Shiori Ohtaku; Yoshihisa Tomioka; Hiroshi Ichinose; Tohru Yamakuni
Journal:  Biochem Biophys Res Commun       Date:  2015-07-27       Impact factor: 3.575

8.  Prenatal cocaine exposure alters potassium-evoked dopamine release dynamics in rat striatum.

Authors:  M F Salvatore; O Hudspeth; L E Arnold; P E Wilson; J A Stanford; C F MacTutus; R M Booze; G A Gerhardt
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys.

Authors:  Michele A Kliem; Nigel T Maidment; Larry C Ackerson; Sugong Chen; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2007-07-18       Impact factor: 2.714

10.  Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice.

Authors:  Alex C Carpenter; Tommy P Saborido; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2012-05-08       Impact factor: 2.984

View more
  18 in total

1.  DOPA Decarboxylase Modulates Tau Toxicity.

Authors:  Rebecca L Kow; Carl Sikkema; Jeanna M Wheeler; Charles W Wilkinson; Brian C Kraemer
Journal:  Biol Psychiatry       Date:  2017-06-15       Impact factor: 13.382

2.  Regulator of G protein signaling-12 modulates the dopamine transporter in ventral striatum and locomotor responses to psychostimulants.

Authors:  Joshua D Gross; Shane W Kaski; Adam B Schroer; Kimberley A Wix; David P Siderovski; Vincent Setola
Journal:  J Psychopharmacol       Date:  2018-01-24       Impact factor: 4.153

3.  Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.

Authors:  Glen Acosta; Nicholas Race; Seth Herr; Joseph Fernandez; Jonathan Tang; Edmond Rogers; Riyi Shi
Journal:  Mol Cell Neurosci       Date:  2019-06-12       Impact factor: 4.314

4.  Tyrosine Hydroxylase Inhibition in Substantia Nigra Decreases Movement Frequency.

Authors:  Michael F Salvatore; Tamara R McInnis; Mark A Cantu; Deana M Apple; Brandon S Pruett
Journal:  Mol Neurobiol       Date:  2018-07-28       Impact factor: 5.590

5.  Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Authors:  Michael F Salvatore; Vicki A Nejtek; Habibeh Khoshbouei
Journal:  Neurotoxicology       Date:  2018-05-18       Impact factor: 4.294

6.  Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.

Authors:  Gabriella E DiCarlo; Jenny I Aguilar; Heinrich Jg Matthies; Fiona E Harrison; Kyle E Bundschuh; Alyssa West; Parastoo Hashemi; Freja Herborg; Mattias Rickhag; Hao Chen; Ulrik Gether; Mark T Wallace; Aurelio Galli
Journal:  J Clin Invest       Date:  2019-05-16       Impact factor: 14.808

7.  Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse.

Authors:  D R Rossato; H Z Rosa; J L O Rosa; L H Milanesi; V G Metz; L F D'Àvila; M E Burger
Journal:  Mol Neurobiol       Date:  2022-06-22       Impact factor: 5.682

8.  Enhanced dopamine D2 autoreceptor function in the adult prefrontal cortex contributes to dopamine hypoactivity following adolescent social stress.

Authors:  Matthew A Weber; Eric T Graack; Jamie L Scholl; Kenneth J Renner; Gina L Forster; Michael J Watt
Journal:  Eur J Neurosci       Date:  2018-07-10       Impact factor: 3.386

9.  Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons.

Authors:  Chloé Berland; Enrica Montalban; Elodie Perrin; Mathieu Di Miceli; Yuko Nakamura; Maud Martinat; Mary Sullivan; Xue S Davis; Mohammad Ali Shenasa; Claire Martin; Stefania Tolu; Fabio Marti; Stephanie Caille; Julien Castel; Sylvie Perez; Casper Gravesen Salinas; Chloé Morel; Jacob Hecksher-Sørensen; Martine Cador; Xavier Fioramonti; Matthias H Tschöp; Sophie Layé; Laurent Venance; Philippe Faure; Thomas S Hnasko; Dana M Small; Giuseppe Gangarossa; Serge H Luquet
Journal:  Cell Metab       Date:  2020-03-05       Impact factor: 27.287

10.  TNFα increases tyrosine hydroxylase expression in human monocytes.

Authors:  Adithya Gopinath; Martin Badov; Madison Francis; Gerry Shaw; Anthony Collins; Douglas R Miller; Carissa A Hansen; Phillip Mackie; Malú Gámez Tansey; Abeer Dagra; Irina Madorsky; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.